Argent Trust CO Astrazeneca PLC Transaction History

Argent Trust CO

$2.75 Billion
Q3 2025

A detailed history of Argent Trust CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Argent Trust CO holds 5,267 shares of AZN stock, worth $470,869. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,267

Previous 6,034 12.71%

Holding current value

$470,869

Previous $421,000 4.04%

% of portfolio

0.01%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$68.72 - $82.11 $52,708 - $62,978	-767 Reduced 12.71%	5,267 $404,000
Q2 2025 Aug 12, 2025	SELL	$64.87 - $75.0 $31,786 - $36,750	-490 Reduced 7.51%	6,034 $421,000
Q1 2025 May 09, 2025	SELL	$65.37 - $77.96 $1,764 - $2,104	-27 Reduced 0.41%	6,524 $479,000
Q3 2024 Nov 13, 2024	SELL	$76.67 - $87.62 $44,851 - $51,257	-585 Reduced 8.2%	6,551 $510,000
Q2 2024 Aug 12, 2024	BUY	$66.81 - $80.83 $41,288 - $49,952	618 Added 9.48%	7,136 $556,000

Q1 2024 May 10, 2024	BUY	$61.03 - $69.57 $31,247 - $35,619	512 Added 8.52%	6,518 $441,000
Q3 2023 Nov 08, 2023	BUY	$64.85 - $71.7 $8,495 - $9,392	131 Added 2.23%	6,006 $406,000
Q1 2023 May 12, 2023	BUY	$63.15 - $71.6 $3,915 - $4,439	62 Added 1.07%	5,875 $407,000
Q4 2022 Feb 10, 2023	SELL	$54.21 - $70.44 $5,529 - $7,184	-102 Reduced 1.72%	5,813 $394,000
Q3 2022 Nov 10, 2022	SELL	$53.02 - $135.75 $6,574 - $16,833	-124 Reduced 2.05%	5,915 $324,000
Q2 2022 Aug 11, 2022	SELL	$59.26 - $71.14 $2,963 - $3,557	-50 Reduced 0.82%	6,039 $399,000
Q1 2022 May 11, 2022	BUY	$55.72 - $67.12 $54,661 - $65,844	981 Added 19.21%	6,089 $404,000
Q4 2021 Feb 09, 2022	SELL	$54.02 - $63.83 $19,987 - $23,617	-370 Reduced 6.75%	5,108 $297,000
Q3 2021 Nov 09, 2021	SELL	$55.56 - $60.79 $222 - $243	-4 Reduced 0.07%	5,478 $329,000
Q2 2021 Aug 09, 2021	BUY	$48.42 - $60.18 $54,908 - $68,244	1,134 Added 26.08%	5,482 $329,000
Q1 2021 May 12, 2021	SELL	$47.16 - $54.44 $6,508 - $7,512	-138 Reduced 3.08%	4,348 $217,000
Q4 2020 Feb 11, 2021	SELL	$48.52 - $58.02 $5,240 - $6,266	-108 Reduced 2.35%	4,486 $224,000
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $243,803 - $280,693	4,594 New	4,594 $252,000
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $439,295 - $532,501	-12,378 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$36.86 - $41.49 $258,536 - $291,010	7,014 Added 130.76%	12,378 $470,000
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $51,305 - $58,626	-1,476 Reduced 21.58%	5,364 $212,000
Q2 2018 Apr 15, 2019	SELL	$34.55 - $37.05 $290,289 - $311,294	-8,402 Reduced 55.12%	6,840 $239,000
Q2 2018 Aug 15, 2018	BUY	$34.55 - $37.05 $526,611 - $564,716	15,242 New	15,242 $536,000

Others Institutions Holding AZN

# of Institutions

1,517

Shares Held

502M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Argent Trust CO with notifications on news.

Account